2021
DOI: 10.1016/j.ces.2021.116776
|View full text |Cite
|
Sign up to set email alerts
|

High-resolution performance tests of nucleation and growth suppression by two kinetic hydrate inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 44 publications
0
10
0
Order By: Relevance
“…The kinetic nucleation parameter, A , is described by CNT as the product of the Zeldovich factor (0.01 < z < 1), the number of available heterogeneous nucleation sites, N 0 , and the frequency of monomer attachment to the growing nucleus, f The thermodynamic parameter, B′ , reflects the work required for nucleation on the active heterogeneous nucleation (HEN) sites. This parameter includes the volume of the solid-forming (hydrate) building unit, v , shape factor of the formed solid cluster, c , and the surface energy of the new solid–fluid interface, σ ef , at the HEN site To extract values of A and B′ from J (Δ T ) data, eq can be linearized: ,,, where Measured (Δ T , J ) data exhibiting a linear trend in the x – y coordinate system defined by eqs and are then characterized by a single pair of A and B ′ parameters. Figure b shows the nucleation rate data presented in Figure a using these linearized coordinates.…”
Section: Resultsmentioning
confidence: 99%
“…The kinetic nucleation parameter, A , is described by CNT as the product of the Zeldovich factor (0.01 < z < 1), the number of available heterogeneous nucleation sites, N 0 , and the frequency of monomer attachment to the growing nucleus, f The thermodynamic parameter, B′ , reflects the work required for nucleation on the active heterogeneous nucleation (HEN) sites. This parameter includes the volume of the solid-forming (hydrate) building unit, v , shape factor of the formed solid cluster, c , and the surface energy of the new solid–fluid interface, σ ef , at the HEN site To extract values of A and B′ from J (Δ T ) data, eq can be linearized: ,,, where Measured (Δ T , J ) data exhibiting a linear trend in the x – y coordinate system defined by eqs and are then characterized by a single pair of A and B ′ parameters. Figure b shows the nucleation rate data presented in Figure a using these linearized coordinates.…”
Section: Resultsmentioning
confidence: 99%
“…Because PVCap is a commercial and effective KHI, it is used to copolymerize with pyrrolidone macromonomers. Additional macromers such as acrylamido propanesulfonic acid and dimethyl aminoethyl methacrylate , have also been used to synthesize terpolymers with VP/VCap copolymers. These co/terpolymers are all commercial KHIs.…”
Section: Performance Of Pyrrolidone-based (Five-membered-ring Lactam)...mentioning
confidence: 99%
“…Over the past three years, an array of these HPS-ALTA cells have been used to record thousands of hydrate formation events, across the range of accessible shear rates and compositions. , Efforts by Metaxas et al configured these cells to study induction time, which enabled a new probabilistic input for field-scale simulation with the above-described mechanistic model; the most recent efforts by Lim and co-workers , and Barwood et al have extended this induction time approach to study various KHIs as a function of concentration, with suggestions that systems containing KHI may not follow classical nucleation theory, which the HPS-ALTA system successfully established for pure guest–water systems . Together, the unique experimental capability and mechanistic model provide a means by which both the probability and severity of a hydrate formation event may be calculated.…”
Section: Structure–function Inhibitor Developmentmentioning
confidence: 99%
“…184 Together, the unique experimental capability and mechanistic model provide a means by which both the probability and severity of a hydrate formation event may be calculated. More importantly, recent efforts by Barwood et al 190 have demonstrated a superior ability to distinguish between KHI formulations and dosages through induction time trials, enabling structure−function development of future KHIs.…”
Section: Structure−function Inhibitormentioning
confidence: 99%